US Stock MarketDetailed Quotes

Ventyx Biosciences (VTYX)

Watchlist
  • 13.890
  • +0.030+0.22%
Close Jan 16 16:00 ET
  • 13.870
  • -0.020-0.14%
Post 20:01 ET
996.61MMarket Cap-9.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ventyx Biosciences (VTYX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.63%-17.51M
13.29%-21.28M
46.00%-25.72M
21.41%-130.87M
54.99%-23.25M
-2.30%-35.46M
50.21%-24.54M
-54.02%-47.63M
-68.59%-166.52M
-9.29%-51.66M
Net income from continuing operations
35.24%-22.83M
15.53%-26.99M
28.86%-27.44M
29.97%-135.12M
37.22%-29.35M
34.76%-35.25M
40.00%-31.95M
0.92%-38.57M
-77.97%-192.96M
-32.77%-46.75M
Operating gains losses
----
----
----
--136K
--36K
--0
--2K
--98K
----
----
Depreciation and amortization
5.50%326K
2.22%323K
-12.75%356K
43.25%1.35M
-21.84%315K
16.60%309K
127.34%316K
204.48%408K
100.21%941K
168.67%403K
Other non cash items
----
----
----
---88K
--0
--0
--0
---88K
----
----
Change In working capital
143.35%1.46M
-47.81%2.13M
85.18%-2.07M
-281.93%-10.56M
129.12%2.7M
-125.41%-3.36M
363.22%4.07M
-512.46%-13.97M
212.58%5.81M
39.46%-9.26M
-Change in prepaid assets
-33.39%1.94M
1,172.15%3.39M
72.41%-1.4M
-125.81%-159K
145.72%2.32M
-59.45%2.92M
94.01%-316K
-235.05%-5.08M
107.39%616K
25.40%-5.06M
-Change in payables and accrued expense
96.43%-216K
-121.88%-1.01M
95.15%-424K
-282.07%-9.56M
114.21%621K
-199.67%-6.05M
20.67%4.62M
-3,092.34%-8.75M
49.76%5.25M
48.02%-4.37M
-Change in other current liabilities
-17.39%-270K
-10.48%-253K
-66.89%-247K
-1,335.59%-847K
-237.14%-240K
-521.62%-230K
-129.00%-229K
-52.58%-148K
81.90%-59K
276.77%175K
Cash from discontinued investing activities
Operating cash flow
50.63%-17.51M
13.29%-21.28M
46.00%-25.72M
21.41%-130.87M
54.99%-23.25M
-2.30%-35.46M
50.21%-24.54M
-54.02%-47.63M
-68.59%-166.52M
-9.29%-51.66M
Investing cash flow
Cash flow from continuing investing activities
-41.70%17.05M
133.36%25.19M
-36.75%26.42M
-115.36%-15.51M
-123.84%-11M
-24.80%29.25M
-316.89%-75.52M
321.04%41.77M
234.71%100.94M
132.75%46.13M
Net PPE purchase and sale
---50K
30.00%-42K
90.86%-16K
53.11%-241K
97.16%-6K
--0
69.23%-60K
-191.67%-175K
-86.91%-514K
-88.39%-211K
Net investment purchase and sale
-41.53%17.1M
133.44%25.23M
-36.98%26.43M
-115.05%-15.27M
-123.72%-10.99M
-24.89%29.25M
-315.51%-75.46M
322.67%41.94M
235.90%101.45M
132.93%46.34M
Cash from discontinued investing activities
Investing cash flow
-41.70%17.05M
133.36%25.19M
-36.75%26.42M
-115.36%-15.51M
-123.84%-11M
-24.80%29.25M
-316.89%-75.52M
321.04%41.77M
234.71%100.94M
132.75%46.13M
Financing cash flow
Cash flow from continuing financing activities
-99.24%203K
107.51%68K
0
128.98%122.12M
-104.27%-25K
1,553.05%26.86M
-136.64%-906K
97.72%96.18M
-68.21%53.33M
105.65%585K
Net common stock issuance
--0
--0
--0
96.34%95.05M
--0
--0
-2,125.53%-1.05M
98.31%96.09M
-70.73%48.41M
--0
Net preferred stock issuance
----
----
----
--26.6M
---247K
----
----
----
--0
--0
Proceeds from stock option exercised by employees
1,591.67%203K
-51.43%68K
--0
-90.53%466K
-48.85%222K
-99.30%12K
-94.55%140K
-57.41%92K
107.29%4.92M
-44.14%434K
Cash from discontinued financing activities
Financing cash flow
-99.24%203K
107.51%68K
--0
128.98%122.12M
-104.27%-25K
1,553.05%26.86M
-136.64%-906K
97.72%96.18M
-68.21%53.33M
105.65%585K
Net cash flow
Beginning cash position
-20.58%33.28M
-79.67%29.05M
-46.27%28.24M
-18.92%52.55M
8.95%62.74M
-18.98%41.9M
124.40%142.87M
-18.92%52.55M
-8.44%64.82M
-78.13%57.59M
Current changes in cash
-101.23%-254K
103.94%3.98M
-99.23%697K
-98.02%-24.26M
-593.06%-34.27M
252.84%20.65M
-742.07%-100.96M
7,820.00%90.32M
-106.63%-12.25M
97.51%-4.95M
Effect of exchange rate changes
-140.10%-77K
2,788.89%242K
2,480.00%119K
-358.33%-55K
-170.93%-233K
1,100.00%192K
-123.68%-9K
-125.00%-5K
71.43%-12K
-1,175.00%-86K
End cash Position
-47.49%32.95M
-20.58%33.28M
-79.67%29.05M
-46.27%28.24M
-46.27%28.24M
8.95%62.74M
-18.98%41.9M
124.40%142.87M
-18.92%52.55M
-18.92%52.55M
Free cash flow
50.49%-17.56M
13.33%-21.32M
46.16%-25.73M
21.51%-131.11M
55.16%-23.26M
-2.16%-35.46M
50.28%-24.6M
-54.29%-47.8M
-68.64%-167.04M
-9.48%-51.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.63%-17.51M13.29%-21.28M46.00%-25.72M21.41%-130.87M54.99%-23.25M-2.30%-35.46M50.21%-24.54M-54.02%-47.63M-68.59%-166.52M-9.29%-51.66M
Net income from continuing operations 35.24%-22.83M15.53%-26.99M28.86%-27.44M29.97%-135.12M37.22%-29.35M34.76%-35.25M40.00%-31.95M0.92%-38.57M-77.97%-192.96M-32.77%-46.75M
Operating gains losses --------------136K--36K--0--2K--98K--------
Depreciation and amortization 5.50%326K2.22%323K-12.75%356K43.25%1.35M-21.84%315K16.60%309K127.34%316K204.48%408K100.21%941K168.67%403K
Other non cash items ---------------88K--0--0--0---88K--------
Change In working capital 143.35%1.46M-47.81%2.13M85.18%-2.07M-281.93%-10.56M129.12%2.7M-125.41%-3.36M363.22%4.07M-512.46%-13.97M212.58%5.81M39.46%-9.26M
-Change in prepaid assets -33.39%1.94M1,172.15%3.39M72.41%-1.4M-125.81%-159K145.72%2.32M-59.45%2.92M94.01%-316K-235.05%-5.08M107.39%616K25.40%-5.06M
-Change in payables and accrued expense 96.43%-216K-121.88%-1.01M95.15%-424K-282.07%-9.56M114.21%621K-199.67%-6.05M20.67%4.62M-3,092.34%-8.75M49.76%5.25M48.02%-4.37M
-Change in other current liabilities -17.39%-270K-10.48%-253K-66.89%-247K-1,335.59%-847K-237.14%-240K-521.62%-230K-129.00%-229K-52.58%-148K81.90%-59K276.77%175K
Cash from discontinued investing activities
Operating cash flow 50.63%-17.51M13.29%-21.28M46.00%-25.72M21.41%-130.87M54.99%-23.25M-2.30%-35.46M50.21%-24.54M-54.02%-47.63M-68.59%-166.52M-9.29%-51.66M
Investing cash flow
Cash flow from continuing investing activities -41.70%17.05M133.36%25.19M-36.75%26.42M-115.36%-15.51M-123.84%-11M-24.80%29.25M-316.89%-75.52M321.04%41.77M234.71%100.94M132.75%46.13M
Net PPE purchase and sale ---50K30.00%-42K90.86%-16K53.11%-241K97.16%-6K--069.23%-60K-191.67%-175K-86.91%-514K-88.39%-211K
Net investment purchase and sale -41.53%17.1M133.44%25.23M-36.98%26.43M-115.05%-15.27M-123.72%-10.99M-24.89%29.25M-315.51%-75.46M322.67%41.94M235.90%101.45M132.93%46.34M
Cash from discontinued investing activities
Investing cash flow -41.70%17.05M133.36%25.19M-36.75%26.42M-115.36%-15.51M-123.84%-11M-24.80%29.25M-316.89%-75.52M321.04%41.77M234.71%100.94M132.75%46.13M
Financing cash flow
Cash flow from continuing financing activities -99.24%203K107.51%68K0128.98%122.12M-104.27%-25K1,553.05%26.86M-136.64%-906K97.72%96.18M-68.21%53.33M105.65%585K
Net common stock issuance --0--0--096.34%95.05M--0--0-2,125.53%-1.05M98.31%96.09M-70.73%48.41M--0
Net preferred stock issuance --------------26.6M---247K--------------0--0
Proceeds from stock option exercised by employees 1,591.67%203K-51.43%68K--0-90.53%466K-48.85%222K-99.30%12K-94.55%140K-57.41%92K107.29%4.92M-44.14%434K
Cash from discontinued financing activities
Financing cash flow -99.24%203K107.51%68K--0128.98%122.12M-104.27%-25K1,553.05%26.86M-136.64%-906K97.72%96.18M-68.21%53.33M105.65%585K
Net cash flow
Beginning cash position -20.58%33.28M-79.67%29.05M-46.27%28.24M-18.92%52.55M8.95%62.74M-18.98%41.9M124.40%142.87M-18.92%52.55M-8.44%64.82M-78.13%57.59M
Current changes in cash -101.23%-254K103.94%3.98M-99.23%697K-98.02%-24.26M-593.06%-34.27M252.84%20.65M-742.07%-100.96M7,820.00%90.32M-106.63%-12.25M97.51%-4.95M
Effect of exchange rate changes -140.10%-77K2,788.89%242K2,480.00%119K-358.33%-55K-170.93%-233K1,100.00%192K-123.68%-9K-125.00%-5K71.43%-12K-1,175.00%-86K
End cash Position -47.49%32.95M-20.58%33.28M-79.67%29.05M-46.27%28.24M-46.27%28.24M8.95%62.74M-18.98%41.9M124.40%142.87M-18.92%52.55M-18.92%52.55M
Free cash flow 50.49%-17.56M13.33%-21.32M46.16%-25.73M21.51%-131.11M55.16%-23.26M-2.16%-35.46M50.28%-24.6M-54.29%-47.8M-68.64%-167.04M-9.48%-51.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.35%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -